The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function
Open accessAbstract
BACKGROUND AND OBJECTIVES: Patients with CKD are more likely than others to have abnormalities in serum potassium (K(+)). Aside from severe hyperkalemia, the clinical significance of K(+) abnormalities is not known. We sought to examine the association of serum K(+) with mortality and hospitalization rates within narrow eGFR strata to understand how the burden of hyperkalemia varies by CKD severity. Associations were examined between serum K(+) and discontinuation of medications that block the renin-angiotensin-aldosterone system (RAAS), which are known to increase serum K(+). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A cohort of patients with CKD (eGFR<60 ml/min per 1.73 m(2)) with serum K(+) data were studied (n=55,266) between January 1, 2009, and June 30, 2013 (study end). Serum K(+), eGFR, and covariates were considered on a time-updated basis. Mortality, major adverse cardiovascular events (MACE), hospitalization, and discontinuation of RAAS blockers were considered per time at risk. RESULTS: During the study, serum K(+) levels of 5.5-5.9 and ≥6.0 mEq/L were most prevalent at lower eGFR: they were present, respectively, in 1.7% and 0.2% of patient-time for eGFR of 50-59 ml/min per 1.73 m(2) versus 7.6% and 1.8% of patient-time for eGFR<30 ml/min per 1.73 m(2). Serum K(+) level <3.5 mEq/L was present in 1.2%-1.4% of patient-time across eGFR strata. The median follow-up time was 2.76 years. There was a U-shaped association between serum K(+) and mortality; pooled adjusted incidence rate ratios were 3.05 (95% confidence interval, 2.53 to 3.68) and 3.31 (95% confidence interval, 2.52 to 4.34) for K(+) levels <3.5 mEq/L and ≥6.0 mEq/L, respectively. Within eGFR strata, there were U-shaped associations of serum K(+) with rates of MACE, hospitalization, and discontinuation of RAAS blockers. CONCLUSIONS: Both hyperkalemia and hypokalemia were independently associated with higher rates of death, MACE, hospitalization, and discontinuation of RAAS blockers in patients with CKD who were not undergoing dialysis. Future studies are needed to determine whether interventions targeted at maintaining normal serum K(+) improve outcomes in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
Andrassy, K. M. (2013) · Kidney International · doi:10.1038/ki.2013.243 · Cited by 2,496
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Einhorn, L. M., Zhan, M., Hsu, V. D., Walker, L. D., Moen, M. F., Seliger, S. L., Weir, M. R., & Fink, J. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.132 · Cited by 646
Ahmed, A., Husain, A., Love, T. E., Gambassi, G., Dell'Italia, L. J., Francis, G. S., Gheorghiade, M., Allman, R. M., Meleth, S., & Bourge, R. C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi890 · Cited by 467
Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
Kovesdy, C. P., Regidor, D. L., Mehrotra, R., Jing, J., McAllister, C. J., Greenland, S., Kopple, J. D., & Kalantar-Zadeh, K. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04451206 · Cited by 361
Acker, C. G., Johnson, J. P., Palevsky, P. M., & Greenberg, A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.917 · Cited by 327
Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?
Sterns, R. H., Rojas, M., Bernstein, P., & Chennupati, S. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010079 · Cited by 303
Severe hyperkalemia requiring hospitalization: predictors of mortality
An, J. N., Lee, J. P., Jeon, H. J., Kim, D. H., Oh, Y. K., Kim, Y. S., & Lim, C. S. (2012) · Critical Care · doi:10.1186/cc11872 · Cited by 291
Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
Weir, M. R., & Rolfe, M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07821109 · Cited by 265
Serum Potassium and Outcomes in CKD: Insights from the RRI-CKD Cohort Study
Korgaonkar, S., Tilea, A., Gillespie, B. W., Kiser, M., Eisele, G., Finkelstein, F., Kotanko, P., Pitt, B., & Saran, R. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05850809 · Cited by 209
Sarafidis, P. A., Blacklock, R., Wood, E., Rumjon, A., Simmonds, S., Fletcher-Rogers, J., Ariyanayagam, R., Al-Yassin, A., Sharpe, C., & Vinen, K. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01150112 · Cited by 183
Role of potassium ion channels in detrusor smooth muscle function and dysfunction
Petkov, G. V. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.194 · Cited by 170
Hypokalemia and Outcomes in Patients With Chronic Heart Failure and Chronic Kidney Disease
Bowling, C. B., Pitt, B., Ahmed, M. I., Aban, I., Sanders, P. W., Mujib, M. U., Campbell, R. C., Love, T. E., Aronow, W. S., Allman, R. M., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.899526 · Cited by 152
Management of patients with acute hyperkalemia
Elliott, M., Ronksley, P. E., Clase, C. M., Ahmed, S. B., & Hemmelgarn, B. R. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100461 · Cited by 116
Damned If You Do, Damned If You Don't
Watson, M. A., Abbott, K. C., & Yuan, C. M. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03700410 · Cited by 90
Dendritic ion channelopathy in acquired epilepsy
Poolos, N. P., & Johnston, D. (2012) · Epilepsia · doi:10.1111/epi.12033 · Cited by 75
Potentially Preventable Hospitalization as a Complication of CKD: A Cohort Study
Wiebe, N., Klarenbach, S. W., Allan, G. M., Manns, B., Pelletier, R., James, M. T., Bello, A. K., Hemmelgarn, B. R., & Tonelli, M. A. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.03.012 · Cited by 55
Disorders of potassium homeostasis: pathophysiology and management.
Hoskote, S. S., Joshi, S., & Ghosh, A. K. (2008) · PubMed · Cited by 51
Endocytic Regulation of Voltage-Dependent Potassium Channels in the Heart
Ishii, K., Norota, I., & Obara, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12r12cp · Cited by 22
Cited by
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Clase, C. M., Carrero, J.-J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., et al. (2020) · Kidney International · doi:10.1016/j.kint.2019.09.018 · Cited by 498
Macdougall, I. C., Bircher, A. J., Eckardt, K.-U., Obrador, G. T., Pollock, C. A., Stenvinkel, P., Swinkels, D. W., Wanner, C., Weiss, G., Chertow, G. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.002 · Cited by 482
Galloway, C. D., Valys, A. V., Shreibati, J. B., Treiman, D. L., Petterson, F. L., Gundotra, V. P., Albert, D. E., Attia, Z. I., Carter, R. E., Asirvatham, S. J., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0640 · Cited by 318
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
Valdivielso, J. M., Rodríguez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., & Ortiz, A. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312705 · Cited by 305
Metadata
- Authors
- Luo, J., Brunelli, S. M., Jensen, D. E., & Yang, A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-01
- Volume
- 11
- Issue
- 1
- Pages
- 90-100
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2219432653
- Cited by
- 288
- References
- 19
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.